相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Applications of Hallucinogens: A Review
Albert Garcia-Romeu et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
Rainer Kraehenmann et al.
BIOLOGICAL PSYCHIATRY (2015)
Can psychedelic compounds play a part in drug dependence therapy?
Ben Sessa et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters
Lucia Burrai et al.
LEGAL MEDICINE (2015)
Withdrawal: Expanding a Key Addiction Construct
Megan E. Piper
NICOTINE & TOBACCO RESEARCH (2015)
Identification and quantitation of 4-bromo-2,5-dimethoxyamphetamine in seized blotters
Lucia Burrai et al.
LEGAL MEDICINE (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
Pharmacological Treatments for Smoking Cessation
Kate Cahill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample
Adam R. Winstock et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Homological scaffolds of brain functional networks
G. Petri et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Hallucinogens - don't choose ignorance
Laura Oxley
PSYCHOLOGIST (2014)
Insula's functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving
Matthew T. Sutherland et al.
PSYCHOPHARMACOLOGY (2013)
Indigenous Supports for Recovery from Alcoholism and Drug Abuse: The Native American Church
Bob Prue
JOURNAL OF ETHNIC & CULTURAL DIVERSITY IN SOCIAL WORK (2013)
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
Matthew W. Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
Michael P. Bogenschutz et al.
DRUG TESTING AND ANALYSIS (2012)
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri S. Krebs et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Determinants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence
Karl Fagerstrom
NICOTINE & TOBACCO RESEARCH (2012)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies
Stephen Ross
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials
Salvatore Mottillo et al.
EUROPEAN HEART JOURNAL (2009)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Support for spirituality in smoking cessation: Results of pilot survey
David Gonzales et al.
NICOTINE & TOBACCO RESEARCH (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom
J McCambridge et al.
ADDICTION (2005)
Hallucinogens and redemption
MD de Rios et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2002)
Jesus, peyote, and the holy people: Alcohol abuse and the ethos of power in Navajo healing
JF Garrity
MEDICAL ANTHROPOLOGY QUARTERLY (2000)
分享论文
